# DLBS1033 as Adjunctive Therapy for Patients With Diabetic Neuropathy

> **NCT07683598** · NA · NOT_YET_RECRUITING · sponsor: **RS H Adam Malik** · enrollment: 80 (estimated)

## Conditions studied

- Diabetic Neuropathy

## Interventions

- **DIETARY_SUPPLEMENT:** DLBS1033
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT07683598
- **Lead sponsor:** RS H Adam Malik
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-01
- **Primary completion:** 2027-02-01
- **Final completion:** 2027-03-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07683598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07683598, "DLBS1033 as Adjunctive Therapy for Patients With Diabetic Neuropathy". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07683598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*